VALSECCHI, MARIA GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 47.154
AS - Asia 23.979
EU - Europa 22.845
SA - Sud America 3.809
AF - Africa 442
Continente sconosciuto - Info sul continente non disponibili 51
OC - Oceania 51
Totale 98.331
Nazione #
US - Stati Uniti d'America 45.977
SG - Singapore 8.936
CN - Cina 5.604
IT - Italia 4.978
HK - Hong Kong 3.679
RU - Federazione Russa 3.650
DE - Germania 3.456
VN - Vietnam 3.144
BR - Brasile 2.968
SE - Svezia 2.788
IE - Irlanda 2.276
UA - Ucraina 1.563
GB - Regno Unito 1.215
CA - Canada 834
IN - India 601
FI - Finlandia 569
FR - Francia 490
AT - Austria 454
KR - Corea 362
ID - Indonesia 338
AR - Argentina 330
NL - Olanda 298
TR - Turchia 240
MX - Messico 239
BD - Bangladesh 236
ZA - Sudafrica 185
DK - Danimarca 183
JP - Giappone 181
ES - Italia 173
PL - Polonia 172
EC - Ecuador 144
IQ - Iraq 133
BE - Belgio 121
CO - Colombia 83
PT - Portogallo 80
PE - Perù 73
PY - Paraguay 61
CL - Cile 60
PK - Pakistan 60
SA - Arabia Saudita 59
CZ - Repubblica Ceca 54
VE - Venezuela 53
EG - Egitto 52
IR - Iran 47
LT - Lituania 46
CH - Svizzera 44
MA - Marocco 43
UZ - Uzbekistan 41
EU - Europa 40
RO - Romania 39
KE - Kenya 38
AE - Emirati Arabi Uniti 36
AU - Australia 34
IL - Israele 26
MD - Moldavia 26
UY - Uruguay 26
JO - Giordania 25
BG - Bulgaria 24
GR - Grecia 23
PH - Filippine 23
MY - Malesia 22
NP - Nepal 22
TH - Thailandia 22
TW - Taiwan 21
AL - Albania 20
DZ - Algeria 19
RS - Serbia 18
TN - Tunisia 18
NZ - Nuova Zelanda 17
PA - Panama 17
NO - Norvegia 16
ET - Etiopia 15
KZ - Kazakistan 15
AZ - Azerbaigian 14
JM - Giamaica 13
SC - Seychelles 13
SK - Slovacchia (Repubblica Slovacca) 13
CR - Costa Rica 12
LB - Libano 12
LV - Lettonia 11
BB - Barbados 10
HU - Ungheria 10
OM - Oman 10
SN - Senegal 10
BO - Bolivia 9
DO - Repubblica Dominicana 9
GT - Guatemala 9
KG - Kirghizistan 9
NG - Nigeria 9
NI - Nicaragua 9
BY - Bielorussia 8
HN - Honduras 8
QA - Qatar 8
LR - Liberia 7
LU - Lussemburgo 7
BH - Bahrain 6
KW - Kuwait 6
UG - Uganda 6
CI - Costa d'Avorio 5
EE - Estonia 5
Totale 98.223
Città #
Ann Arbor 8.079
Singapore 5.174
Ashburn 3.883
Woodbridge 3.779
Hong Kong 3.650
Fairfield 3.303
Chandler 2.501
Houston 2.496
Frankfurt am Main 2.227
Dublin 2.199
Wilmington 1.765
Jacksonville 1.593
Milan 1.342
Seattle 1.295
New York 1.237
Cambridge 1.148
Dearborn 1.046
Santa Clara 954
Ho Chi Minh City 940
Beijing 877
Princeton 846
Dallas 745
Hanoi 735
Los Angeles 723
Hefei 710
Nanjing 480
Shanghai 409
Altamura 403
Lawrence 397
Chicago 376
Vienna 351
The Dalles 345
Seoul 331
Moscow 318
Buffalo 288
Jakarta 276
São Paulo 274
Lachine 269
Guangzhou 214
San Diego 204
Rome 194
Boardman 190
London 182
Munich 175
Council Bluffs 172
Helsinki 167
Nanchang 156
Toronto 151
Andover 134
Nuremberg 134
Warsaw 133
Shenyang 129
Tianjin 126
Ottawa 116
Lissone 115
Dong Ket 113
Rio de Janeiro 112
Tokyo 109
Hebei 108
Changsha 107
Salt Lake City 106
Brooklyn 103
Montreal 103
Brussels 98
Johannesburg 96
Haiphong 92
Jinan 92
Denver 88
Orem 87
Norwalk 82
Poplar 82
Chennai 81
Columbus 80
San Jose 79
Falls Church 78
Boston 76
Mountain View 76
Fremont 74
Biên Hòa 73
Jiaxing 73
Quận Bình Thạnh 72
Stockholm 72
Bologna 69
Atlanta 68
Ha Long 67
Huizen 67
Monza 67
Turku 66
Mexico City 64
Phoenix 61
Belo Horizonte 60
Brasília 59
San Francisco 58
Zhengzhou 56
Da Nang 54
Lappeenranta 54
Tampa 54
Amsterdam 53
Hangzhou 53
Guayaquil 52
Totale 63.950
Nome #
New concepts on the clinical course and stratification of compensated and decompensated cirrhosis 1.175
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome 655
Clinical states of cirrhosis and competing risks 527
Oncologic and fertility impact of surgical approach for borderline ovarian tumours treated with fertility sparing surgery 469
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 456
Four Additional Doses of PEG-L-Asparaginase during the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study 452
Enzymatic replacement therapy for Hunter disease: Up to 9 years experience with 17 patients 425
The SIPI for measuring complexity in nursing care: Evaluation study 404
Late mortality and causes of death among 5-year survivors of childhood cancer diagnosed in the period 1960–1999 and registered in the Italian Off-Therapy Registry 400
Effects of antenatal indomethacin on ductus arteriosus early closure and on adverse outcomes in preterm neonates 398
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery 393
Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib 387
Predictive value of minimal residual disease in philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies 386
Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years 381
IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia 376
Clinical features and outcome of SIL/TAL1-positive t-cell acute lymphoblastic leukemia in children and adolescents: A 10-year experience of the AIEOP group 375
Nomograms to identify elevated blood pressure values and left ventricular hypertrophy in a paediatric population: American Academy of Pediatrics Clinical Practice vs. Fourth Report/European Society of Hypertension Guidelines 375
Sleeping Beauty-engineered CAR T cells achieve anti-leukemic activity without severe toxicities 373
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 371
Pentraxin 3 plasma levels at graft-versus-host disease onset predict disease severity and response to therapy in children given haematopoietic stem cell transplantation 357
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System 356
Noninvasive Ventilatory Support of COVID-19 Patients Outside the Intensive Care Units (WARd-COVID) 355
The relationship between frailty and delirium: insights from the 2017 Delirium Day study 343
Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis 340
Multi-center randomized controlled trial on the effect of triclosan-coated sutures on surgical site infection after colorectal surgery 339
ActivinA: a new leukemia-promoting factor conferring migratory advantage to B-cell precursor-acute lymphoblastic leukemic cells 338
Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia 338
Imatinib long term effects study: three years of follow-up and assessment 336
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 335
A new prognostic index of severity of intellectual disabilities in Cornelia de Lange syndrome 334
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 327
Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint 327
Effects of lifestyle modifications on elevated blood pressure and excess weight in a population of Italian children and adolescents 325
Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection 324
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 324
Three-year National report from the Gruppo Italiano di Ortogeriatria (GIOG) in the management of hip-fractured patients 320
Impact of Continuous vs Bolus Feeding on Splanchnic Perfusion in Very Low Birth Weight Infants: A Randomized Trial 319
Modeling the hazard of transition into the absorbing state in the illness-death model 318
How do self-care maintenance, self-care monitoring, and self-care management affect glycated haemoglobin in adults with type 2 diabetes? A multicentre observational study 318
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 317
Validation of the Italian version of the full and abbreviated Trust in Oncologist Scale 316
Indicators of guideline-concordant care in lung cancer defined with a modified Delphi method and piloted in a cohort of over 5,800 cases 316
Validation of a skewed surrogate endpoint for a time-to-event outcome: the use of a Zaga distribution 312
Glutamine-enriched intravenous total parenteral nutrition doesn't improve mucositis and clinical outcome after stem cell transplantation for childhood malignancies. A prospective double- blind controlled study on behalf of AIEOP Group 312
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 310
Carotid plaque echolucency increases the risk of stroke in carotid stenting: The imaging in carotid angioplasty and risk of stroke (ICAROS) study 309
Complexity of nursing care at 24 h from admission predicts in-hospital mortality in medical units: A cohort study 309
A second update on mapping the human genetic architecture of COVID-19 308
Basket trials in very rare diseases: are they feasible? 307
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 307
Effectiveness of treatments for acute and sub-acute mechanical non-specific low back pain: Protocol for a systematic review and network meta-analysis 302
Reduced-Intensity delayed intensification in standard-Risk pediatric acute lymphoblastic leukemia defined by undetectable minimal residual disease: Results of an international randomized trial (AIEOP-BFM ALL 2000) 299
Graphical representations and summary indicators to assess the performance of risk predictors 296
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 295
Mapping the human genetic architecture of COVID-19 292
Body temperature at nursery admission in a cohort of healthy newborn infants: Results from an observational cross-sectional study 291
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL 290
BIVARIATE COPULA MODELS IN THE PRESENCE OF COMPLEX PATTERNS FOR THE SURROGATE ENDPOINT FOR A SURVIVAL TRUE ENDPOINT 288
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 288
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 281
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 279
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 277
Risk stratification of oxaliplatin induced peripheral neurotoxicity applying electrophysiological testing of dorsal sural nerve 276
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 276
Uric acid in chronic coronary syndromes: Relationship with coronary artery disease severity and left ventricular diastolic parameter 276
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 274
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detection 273
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 271
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 271
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 267
Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study 267
Autologous Purified Peripheral Blood Stem Cell Transplantation Compare to Chemotherapy in Childhood Acute Lymphoblastic Leukemia after Low-Risk Relapse 266
Factors Influencing Access to Transplant, Waitlist Mortality, and Post-Transplant Survival in the Italian National Heart Transplant Database 266
Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases 265
Long-term follow up of pediatric Philadelphia positive acute lymphoblastic leukemia treated with the EsPhALL2004 study: High white blood cell count at diagnosis is the strongest prognostic factor 265
Usefulness of waist circumference for the identification of childhood hypertension 264
Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia 264
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 264
Increased serum uric acid levels blunt the antihypertensive efficacy of lifestyle modifications in children at cardiovascular risk 262
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 261
Sudden death and associated factors in a historical cohort of chronic haemodialysis patients 259
Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T 259
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 258
Association between uric acid and pulse wave velocity in hypertensive patients and in the general population: a systematic review and meta-analysis 257
Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin 255
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 255
Atrial fibrillation and low vitamin D levels are associated with severe vascular calcifications in hemodialysis patients 255
CRLF2 over-expression is a poor prognostic marker in children with high risk T-cell acute lymphoblastic leukemia 255
Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants 255
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 254
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 254
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia 253
Adverse events in single-arm clinical trials with non-fatal time-to-event efficacy endpoint: from clinical questions to methods for statistical analysis 251
High-throughput screening as a drug repurposing strategy for poor outcome subgroups of pediatric B-cell precursor Acute Lymphoblastic Leukemia 251
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 251
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach 251
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 250
A randomized and controlled study of noninvasive hemodynamicmonitoring as a guide to drug treatment of uncontrolled hypertensive patients 250
The treatment of childhood acute lymphoblastic leukemia in Guatemala: Biologic features, treatment hurdles, and results 250
MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: A randomised controlled trial protocol 250
Totale 32.253
Categoria #
all - tutte 341.852
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 341.852


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215.944 0 0 0 0 0 906 980 891 775 1.001 616 775
2021/20226.287 477 642 716 586 427 468 335 313 373 432 527 991
2022/202310.939 1.185 3.076 925 1.011 813 1.669 157 623 737 117 381 245
2023/20247.673 269 266 396 480 990 1.856 1.415 251 583 210 151 806
2024/202518.405 1.125 2.061 1.248 932 1.549 798 1.101 705 1.911 2.508 1.619 2.848
2025/202623.381 5.645 2.922 3.211 4.491 5.175 1.937 0 0 0 0 0 0
Totale 100.598